baber/WOPTO huggingface dataset:
Patent DK-1276394-T3 (DK)
Inventor: WENGER LAVON G
IPC: A23P1/12
Filed: 2001-03-28
Granted: 2008-10-06
Abstract: Improved, high-capacity extrusion systems (20, 220) are provided which minimize product losses and permit the user to conduct multiple, segregated short extrusion runs with a minimum of down time between runs. The systems (20, 220) include an extruder assembly (21, 221) having a special, multiple-position die assembly (28), as well as an upstream preconditioner (24) and feed bin assembly (22). A variable speed, variable output discharge screw feeder (78) is located between the preconditioner outlet (62) and extruder barrel inlet (90). A PLC-type controller (30) coupled to the extruder assembly components establishes a choke full condition at the discharge feeder (78) so that continuous uninterrupted flow of preconditioned material to the extruder (26) at a uniform mass flow rate is maintained for as long as possible. In preferred forms, load cells (46, 72) are operatively coupled to the bin assembly (22) and preconditioner (24) so as to monitor material flow through the systems (20, 220). A multiple stage cascade-type dryer assembly (29) is provided downstream of extruder (26). The assembly (29) is controlled via the controller (30) in coordination with the extruder assemblies (21, 221) so as to maintain the segregation between separate product runs throughout the drying operation.
Patent DK-1248864-T3 (DK)
Inventor: PRENGAMAN R DAVID
IPC: H01M4/73
Filed: 2001-01-17
Granted: 2007-04-10
Abstract: A lead acid battery grid made from a lead based alloy containing calcium, tin, and silver having the following composition: calcium above 0.06 and below 0.082 %, tin above 1.0 % and below 1.2 %, silver between 0.005 and 0.020 %, and optionally containing up to 0.025 % aluminum. To enhance corrosion resistance and reduce grid growth, the grid optimally may contain 0.005 to 0.05 % copper as an alloying element complementary to and as a replacement for part of the silver, provided the silver content does not fall below 0.005 % and no more than a trace of aluminum is present.
Patent DK-1332035-T3 (DK)
Inventor: BACHER HELMUT
IPC: B29C48/475
Filed: 2001-09-19
Granted: 2005-10-24
Abstract: An apparatus for filtering viscous material, in particular thermoplastic synthetic plastic material, comprises a screw ( 24 ), which presses the material to be cleaned from an upstream conduit ( 3 ) of a supply housing ( 2 ) towards a band-shaped screen ( 4 ). The screen ( 4 ) is abutted on its downstream side by a perforated plate ( 6 ) against the pressure of the supplied material. The band-shaped screen ( 4 ) can be displaced for replacement of a soiled band section by a fresh band section. For facilitating this displacement a device is provided, which comprises a closure means ( 30 ) that is disposed on the upstream side of the screen ( 4 ), by which closure means the upstream conduit ( 3 ) for the material to be filtered can be closed at least substantially. On the upstream side of this closure means ( 30 ) a storage space ( 36 ) for material to be cleaned is connected to the upstream conduit ( 3 ). Within this storage space ( 36 ) a piston ( 38 ) is sealingly guided, which is reciprocable by a drive means and closes in its projected position the storage space ( 36 ) against the upstream conduit ( 3 ).
Patent DK-1245890-T3 (DK)
Inventor: HOEINGHAUS EWALD
IPC: F16L23/22
Filed: 2002-02-23
Granted: 2004-10-25
Abstract: A sealing element (1,1') for connecting two pipe rims (11,12) consists of a ring shaped section and a sealing section. An elastic sealing lip (5) is located at the sealing sections, and presses against the pipe rim. The sealing lips are located on opposite sides of the sealing sections. The sealing element consists of NBR, silicone, EPDM, FKM-FPM, or a mixture of these materials.
Patent DK-1308447-T3 (DK)
Inventor: MEIJER LAURENT
IPC: A61P25/28
Filed: 1996-11-29
Granted: 2011-06-20
Abstract: Purine derivatives of formula (I) in optically-active or racemic forms and optionally as geometric isomers, having an IC50 ≤ 5 mu M for cdc2/cyclin B (cdc = catalytic subunit of a cyclin-dependent protein kinase (cdk); cyclin = the regulatory subunit) are new. In (I), R2, R6 and R9 = halo, RNH, RNH-NH, NH2-R'-NH- or RNH-R'-NH-; R = alkyl, aryl, cycloalkyl or heterocyclyl; R' = alkylene, arylene or cycloalkylene; both R and R' have 1-8 C and are optionally substituted by OH, halo, amino or alkyl; R2 may also be heterocyclyl, optionally substituted by R; R9 may also be alkyl, aryl or cycloalkyl; R2 and R9 can also be H but with provisos e.g.(a) R6, R9 = benzylamino and Me; and (b) R2, R6 = 2-hydroxyethylamino and benzylamino.
Patent DK-1406641-T3 (DK)
Inventor: SAMPALIS TINA
IPC: A61K35/612
Filed: 2002-06-07
Granted: 2009-05-04
Abstract: The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport enhancement. The method comprises the administration of a therapeutically effective amount of krill and/or marine oil to a patient. The present invention also relates to a composition for the treatment and/or prevention of these diseases.
Patent DK-1419167-T3 (DK)
Inventor: EISENBARTH JOSEF ANTONIUS MARI
IPC: C07H19/06
Filed: 2002-08-21
Granted: 2005-06-13
Abstract: What is described are compounds wherein R represents Br, I or R<SUP>1</SUP>-SO<SUB>3</SUB>, where R<SUP>1 </SUP>is an unsubstituted or substituted C<SUB>1</SUB>-C<SUB>5</SUB>-alkyl group, or an unsubstituted or substituted phenyl group; X is O or NR'', where R'' is a usual protective group for N; and R' represents hydrogen, a halogen, such as F, Cl, and Br, a substituted or unsubstituted C<SUB>1</SUB>-C<SUB>7</SUB>-alkyl group, such as methyl and ethyl, a substituted or unsubstituted C<SUB>2</SUB>-C<SUB>7</SUB>-alkenyl group, or a substituted or unsubstituted C<SUB>2</SUB>-C<SUB>7</SUB>-alkynyl group.
Patent DK-1556058-T3 (DK)
Inventor: COELINGH BENNINK HERMAN JAN TI
IPC: A61P35/00
Filed: 2003-10-23
Granted: 2008-03-03
Abstract: The estrogenic component according to the invention is particularly useful in the treatment or prevention of colorectal and prostate cancer and, unlike commonly used estrogens, does not simultaneously enhance the risk of estrogen-stimulated cancers such as breast cancer.
Patent DK-1622908-T3 (DK)
Inventor: KALLA RAO
IPC: C07D473/06
Filed: 2003-05-06
Granted: 2008-11-17
Abstract: Disclosed are compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
Patent DK-1674057-T3 (DK)
Inventor: BERG CHRISTIAN
IPC: A61F11/06
Filed: 2004-12-23
Granted: 2009-01-05
Abstract: The invention relates to a hearing protection device comprising two earplugs (10, 12) to be worn at least in part in a user's right and left ear canal, respectively, and flexible means (14) for mechanically connecting the two earplugs, wherein at least one of said earplugs comprises an acoustic output transducer (32), wherein said connecting means comprises an antenna (24), wherein at least one of said earplugs comprises an electromagnetic signal receiving unit (26) electrically connected to said antenna and to said output transducer, and wherein said hearing protection device is adapted for wireless electromagnetic communication with a remote unit (36, 38, 40) via said antenna.
Patent DK-1466803-T3 (DK)
Inventor: ERHARD KARL-HEINZ DR
IPC: B61L3/00
Filed: 2004-02-25
Granted: 2006-09-11
Abstract: The method involves specifying a speed depending on a bend and possibly lateness relative to a travel plan. Travel time reserves are defined for route sections in relation to a maximum permissible section speed. The train location according to the travel plane is determined using the plan and current time. The speed to be defined is computed from the bend applicable to this location and the current lateness taking into account the travel time reserve.
Patent DK-1696765-T3 (DK)
Inventor: BROOKE RORY
IPC: A47B91/16
Filed: 2004-10-07
Granted: 2007-11-19
Abstract: The invention relates to a self-stabilizing support assembly (14) for an item of furniture, such as a table, stool or chair. The assembly includes a support structure (16) for connection at an upper end thereof to an upper portion of an item of furniture. The support structure has a first pair of feet (50) at a lower end (22) thereof. An elongated guides pin (38) projects from a lower end of the support structure. A displaceable support member (30), which has a second pair of feet (32), is provided with a housing (36) defining a guide passage, in which guide passage the guide pin is longitudinally slidably received. The housing is constructed such that a cross-sectional area of the guide passage is adjustable, to permit dimensioning of the guide passage relative to the guide pin such that automatic frictional engagement of the guide pin with walls of the housing defining the guide passage occurs in response to pivoting of the displaceable support member about a pivot axis transverse to the housing, to anchor the displaceable support member frictionally against sliding displacement relative to the guide pin.
Patent DK-1670110-T3 (DK)
Inventor: EBERLE PATRICK
IPC: H02G3/04
Filed: 2005-11-26
Granted: 2009-03-23
Abstract: An end-plate has five separate elements (10-50). One plate is the base plate (10) with a terminal board (170 matched to the wiring and cabling arrangement channel, and two pairs of pins (32,52) matched terminal-wise to the opening (15) in the base plate (10). An extension (41') of the intermediate plate (40) carries a pin (44) terminal-wise matched to the opening (15) and an opening (45) terminal-wise matched to the opening pin (22) of the other intermediate plate (20). An extension (51') of the corner plate (50) carries a pair of pins (54) terminal-wise matched to the openings (15) of the base plate (10).
Patent DK-1683522-T3 (DK)
Inventor: TIRAULT MYRIAM
IPC: A61K31/4468
Filed: 2005-12-30
Granted: 2009-01-12
Abstract: Use of a nefopam compound (I), or its salt, for the preparation of a drug to prevent or treat the acute tolerance of morphine or the hyper-analgesic effect due to morphine administration. Use of a nefopam compound of formula (I), or its salt, for the preparation of a drug to prevent or treat the acute tolerance of morphine or the hyper-analgesic effect due to morphine administration. R 5O or is absent; R 6 and R jH or 1-6C alkyl; n : 2-4; j : 1-n; R 7phenyl, optionally substituted one or more times by H, 1-6C alkyl, 1-6 alkoxy, CF 3 or halo; and R 8-R 11H, 1-6C alkyl, 1-6 alkoxy, CF 3 or halo. An independent claim is also included for a product containing (I) and/or a morphine analgesia (to induce an analgesic effect), where (I) prevents or treats the acute tolerance of morphine or hyper-analgesic effect due to morphine. [Image] ACTIVITY : Analgesic. MECHANISM OF ACTION : N-methyl-d-aspartate receptor antagonist.
Patent DK-1709416-T3 (DK)
Inventor: MORTENSEN IVAN ENGMARK
IPC: G01M11/08
Filed: 2005-01-20
Granted: 2018-06-18
Abstract: The present invention relates to a connector box adapted to be at least partly I embedded in a fibre-reinforced part of a wind turbine, where said connector box comprises a flexible base part and a sealing part. The sealing part seals off and protects at least one compartment between the sealing part and the base part during manufacture of said fibre-reinforced part, but can be partly removed after manufacture making said compartment accessible. The base part is adapted to fasten the connector box in the fibre-reinforced part by having a larger circumference near its bottom than near its top. Further, the invention relates to such a connector box fixating a part of an element in the compartment of the box and making a second part of the element accessible from the compartment after manufacture.
Patent DK-1997117-T3 (DK)
Inventor: HOPPE JENS
IPC: H01F27/04
Filed: 2007-03-15
Granted: 2010-04-06
Abstract: A connecting element between a first electric shielding assembly that surrounds a cable feedthrough and includes at least one tubular insulating barrier that surrounds the cable feedthrough and at least one second electric shielding assembly that surrounds the cable feedthrough and includes at least one tubular insulating barrier that surrounds the cable feedthrough. A continuous barrier system around the cable feedthrough is provided by a connecting element with at least two interconnecting insulating barriers, which can be inserted into the shielding assemblies, even if the shielding assembly is configured from sub-segments. The disclosure also relates to an electric shield for a cable feedthrough and to a method for producing an electric shield for a cable feedthrough.
Patent DK-2169852-T3 (DK)
Inventor: CHEN JUAN
IPC: H04B10/29
Filed: 2008-08-05
Granted: 2012-01-23
Abstract: A method, a device, and a system for realizing data transmission extension in a passive optical network (PON) are provided. Between a burst-mode clock and data recovery (BCDR) module and an electrical-optical (E/O) amplification module, the device includes a delimiter matching module and a preamble buffering and compensating module. The delimiter matching module is adapted to receive a data frame sent by the BCDR module and determine a location of a delimiter in the data frame. An optical-electrical (O/E) amplification module performs O/E conversion, amplification, and shaping on the data frame. The BCDR module then performs clock and data recovery processing on the data frame. The preamble buffering and compensating module is adapted to receive and buffer the data frame output from the delimiter matching module, insert a compensation preamble in the data frame according to the location of the delimiter in the data frame determined by the delimiter matching module, and send the data frame to the E/O amplification module according to a retiming clock of a downstream direction. Therefore, the data transmission extension is realized in an optical-electrical-optical (OEO) manner.
Patent DK-2287371-T3 (DK)
Inventor: SAKAMOTO GODO
IPC: D01F6/04
Filed: 2004-12-03
Granted: 2012-11-26
Abstract: PURPOSE: To provide a novel high strength polyethylene multifilament which consists of a plurality of filaments having high strengths and uniform internal structures, and showing a narrow variation in the strengths of the monofilaments, and which has been difficult to be provided by the conventional gel spinning method.  SOLUTION: A high strength polyethylene multifilament consisting of a. plurality of filaments which are  characterized in that  the stress Raman shift factor is - 5.0 cm -1  / (cN/dTex) or more; the crystal size of monoclinic crystal is 9 nm or less, the average strength is 20 CN/dTex or higher; the knot strength retention of each monofiiament is 40% or higher; CV indicating a variation in the strengths of the monofilaments is 25% or lower; the elongation at break is from 2.5% inclusive to 6.0% inclusive; the fineness of each filament is 10 dTex or less; and the melting point of the filaments is 145°C or higher.
Patent DK-3006443-T3 (DK)
Inventor: ISHIHARA TSUKASA
IPC: C07D413/10
Filed: 2014-06-06
Granted: 2018-06-25
Abstract: The inventors perfected the present invention as a result of a study into IK1 channel activators and a confirmation that a benzothiophene compound exhibits efficacy against visceral pain, inflammatory pain, osteoarthritic pain, neuropathic pain, or fibromyalgia. This compound, represented by formula (I), has IK1 channel activating action, and may be used as a drug to prevent or treat visceral pain, inflammatory pain, osteoarthritic pain, neuropathic pain, fibromyalgia, or the like. The IK1 channel activator may be used as a drug to prevent or treat inflammatory pain, osteoarthritic pain, neuropathic pain, or fibromyalgia.
Patent DK-3137242-T3 (DK)
Inventor: DI SERIO EMILE THOMAS
IPC: B22F3/17
Filed: 2015-04-22
Granted: 2018-07-23
Abstract: The invention relates to a method for the production of a part made from metal alloy or metal matrix composite materials, in which a preform is produced by means of additive manufacturing in which material is added via the stacking of successive layers and the preform is subjected to a one-step forging operation between two dies in order to obtain the end shape of the part to be produced.
Patent DK-0387671-T3 (DK)
Inventor: MARCHAND GARY R
IPC: C08C2/00
Filed: 1990-03-07
Granted: 1993-12-06
Abstract: A process for preparing polymers by means of the anionic polymerization of polymerizable monomers comprising contacting one or more anionically polymerizable monomers with an alkalimetal-containing anionic initiator under anionic polymerization condition characterized by terminating the polymerization by contacting the reaction mixture with an inorganic acid selected from sulfuric acid, phosphoric acid and mixtures thereof.
Patent DK-0394830-T3 (DK)
Inventor: REBER ERWIN
IPC: A01B61/04
Filed: 1990-04-19
Granted: 1993-03-22
Abstract: In a tractor-mounted agricultural tool, especially a circular mower, which is connected to a supporting frame (7) rotatably about a transverse axis, there are provided between the supporting frame (7) and the machine mounting (9) articulated connections which ensure that the machine mounting (9) together with the mowing implements (10) can shift upwards and rearwards when a centrally or eccentrically acting longitudinal force is exerted on the mower, for example as a result of an obstacle. At the same time, the lift occurs on the side of the mower on which the longitudinal force is applied. Various articulated connections for achieving the object are described. <IMAGE>
Patent DK-0409510-T3 (DK)
Inventor: SHORTT FREDERICK JOHN
IPC: B31F1/28
Filed: 1990-07-13
Granted: 1995-05-29
Abstract: A heat transfer system particularly though not exclusively for assisting the bonding of a continuous liner sheet to a single faced board in a corrugating machine where the single faced board (10), after gluing of the corrugated tips is brought together with the liner (12) and conveyed across a series of hot plates (15), the invention consisting of a series of vessels (20) containing a liquid or gas arranged above the conveyed board to press same uniformly in contact with the hot plate surface irrespective of distortion or undulation thereof thus to ensure adequate heat transfer and avoid damage to the board.
Patent DK-0462166-T3 (DK)
Inventor: PARNALL SIMON JOHN
IPC: H04B1/16
Filed: 1990-03-08
Granted: 1996-11-25
Abstract: The method is for transmitting radio data system signals accompanying a programme in groups of an extended other network type. The RDS data comprises first to fourth blocks, the first block carrying the programme identification code (PI(TN)) of the programme. The second block carries a group type code (GT) identifying the extended other network type as well as a multiple variant usage code (UC) identifying which of a selection of items of information is carried in the third block. These items of information pertain to the other networks programme identified in the fourth block by its programme identification code (PI(ON)). The programme identification codes comprise a country code, an area coverage code and a programme reference code. One usage code (UC) in the second block identifies a transmission of a linkage word (12) in the third block carrying information related to the programme identification code of the programme or programmes to be linked to the programme identified in the fourth block.
Patent DK-0469074-T3 (DK)
Inventor: SHAW GRAY
IPC: C12R1/19
Filed: 1990-04-19
Granted: 1996-08-26
Abstract: Cysteine added variants ("CAVs") of G-CSF are provided having one or more cysteine residues substituted for selected naturally occurring amino acid residues, or inserted into the polypeptide sequence, and preferably being further modified by deletion of certain N-terminal amino acids. Such CAVs may be additionally modified by the coupling of sulfhydryl reactive compounds to the introduced cysteine residue(s) without loss of bioactivity to produce selected homogeneously modified G-CSF and improved pharmaceutical compositions containing the same.
Patent DK-0464533-T3 (DK)
Inventor: LAUFFER LEANDER DR
IPC: C07K14/705
Filed: 1991-06-22
Granted: 1999-04-26
Abstract: A soluble fusion protein (I) comprising a human protein (II), or part of it, that is not of the immunoglobulin (Ig) family and different parts (III) of Ig molecules of any subclass, is new. An independent claim is also included for a method for preparing (I) by introducing a DNA that encodes it into a mammalian cell expression system, expressing (I), and purification by affinity chromatography through the Ig component. ACTIVITY : Hemostatic; Immunosuppressive; Antiallergic; Antianemic; Anticoagulant; Thrombolytic. No details of tests for these activities are given. MECHANISM OF ACTION : Protein substitution or inhibition.
Patent DK-0447004-T3 (DK)
Inventor: GILKERSON TERENCE
IPC: C07D213/78
Filed: 1991-03-12
Granted: 1998-09-23
Abstract: The invention provides compounds of the general formula <CHEM>  in which   R<1> represents a hydrogen or halogen atom or an alkyl or haloalkyl group; the or each group X independently represents a halogen atom or an optionally substituted alkyl or alkoxy group or an alkenyloxy, alkynyloxy, cyano, carboxy, alkoxycarbonyl, (alkylthio)carbonyl, alkylcarbonyl, amido, alkylamido, nitro, alkylthio, haloalkylthio, alkenylthio, alkynylthio, alkylsulphinyl, alkylsulphonyl, alkyloximinoalkyl or alkenyloximinoalkyl group;   n is 0 or an integer from 1 to 5; and L is an alkoxy group.EM
Patent DK-0456361-T3 (DK)
Inventor: OLSEN ROBERT
IPC: B65D71/50
Filed: 1991-04-17
Granted: 1995-10-30
Abstract: Carrier stock (10) is formed from a single sheet of resilient polymeric material, such as low density polyethylene, for machine application to side walls of substantially identical containers (12). Integrally joined band segments (22,24,26,28,32,34,36,40) defining separate apertures (14) to receive the individual containers (12) include longitudinal (22,24), cross (32,34,36,40), and diagonal (26,28) segments. The diagonal segments (26,28) are joined together at generally X-shaped junctions (42). From each junction (42), the generally oblique segments of a first pair (26a,28a) are continuously curved toward the nearer edge of such stock (10) and the diagonal segments of a second pair (26b,28b) are substantially straight and tend toward the other edge of such stock. Each diagonal segment (26a, 28a) of the first pair at each junction has a progressively changing width, being wider at its end (48) joined at such junction (42) than at its other end (46). Each diagonal segment (26b,28b) of the second pair at each junction has a substantially uniform width. <IMAGE>
Patent DK-0458949-T3 (DK)
Inventor: KOHNERT ULRICH
IPC: B65G53/58
Filed: 1990-12-19
Granted: 1995-10-02
Abstract: The invention relates to a pharmaceutical preparation of a non-glycosylized t-PA derivative, K1K2P pro, with an enzymatic activity of at least 0.4 MU/ml and a pH of 4.5 to 6, containing citrate and at least one compound from the following group: a) ascorbic acid, b) EDTA, c) amino compounds of formula R?1R?2N -R - X, where X = SO3?H, CH(NH2?)-CO2?H, CO2?H, H, NH2? or OH, R = C1?-C9? alkylene, C3?-C6? cycloalkylene or benzylidene and R?1 and R?2, independently of each other, are H or C1?-C3? alkyl, d) guianidinobutyric acid, e) dimethylbiguanide, f) arginine, g) glucosamine, fructose, h) pyrimidine nucleosides and pyrimidine nucleotides, i) carboxylic acids substituted with one or more hydroxyl, keto and/or further carboxyl groups. The invention also relates to a drug containing the t-PA derivative K1K2P pro as the active ingredient and a process for producing it.